V E Valkhoff

Summary

Affiliation: Erasmus MC
Country: The Netherlands

Publications

  1. pmc Population-based analysis of non-steroidal anti-inflammatory drug use among children in four European countries in the SOS project: what size of data platforms and which study designs do we need to assess safety issues?
    Vera E Valkhoff
    Department of Medical Informatics, Erasmus University Medical Center, Dr, Molewaterplein, Rotterdam, The Netherlands
    BMC Pediatr 13:192. 2013
  2. ncbi Prescription of nonselective NSAIDs, coxibs and gastroprotective agents in the era of rofecoxib withdrawal - a 617,400-patient study
    V E Valkhoff
    Department of Medical Informatics, Erasmus University Medical Centre, Rotterdam, The Netherlands
    Aliment Pharmacol Ther 36:790-9. 2012
  3. ncbi Adherence to gastroprotection during cyclooxygenase 2 inhibitor treatment and the risk of upper gastrointestinal tract events: a population-based study
    Vera E Valkhoff
    Erasmus University Medical Centre, Rotterdam, The Netherlands
    Arthritis Rheum 64:2792-802. 2012
  4. ncbi Risk factors for gastrointestinal bleeding associated with low-dose aspirin
    Vera E Valkhoff
    Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, The Netherlands
    Best Pract Res Clin Gastroenterol 26:125-40. 2012
  5. ncbi Time-trends in gastroprotection with nonsteroidal anti-inflammatory drugs (NSAIDs)
    V E Valkhoff
    Department of Gastroenterology and Hepatology, Erasmus University Medical Centre, Rotterdam, The Netherlands
    Aliment Pharmacol Ther 31:1218-28. 2010
  6. ncbi Risk of recurrent myocardial infarction with the concomitant use of clopidogrel and proton pump inhibitors
    V E Valkhoff
    Department of Gastroenterology and Hepatology, Erasmus University Medical Centre, Rotterdam, The Netherlands
    Aliment Pharmacol Ther 33:77-88. 2011
  7. pmc Cyclo-oxygenase-2 inhibitors or nonselective NSAIDs plus gastroprotective agents: what to prescribe in daily clinical practice?
    G M C Masclee
    Department of Medical Informatics, Erasmus University Medical Centre, Rotterdam, The Netherlands
    Aliment Pharmacol Ther 38:178-89. 2013

Detail Information

Publications7

  1. pmc Population-based analysis of non-steroidal anti-inflammatory drug use among children in four European countries in the SOS project: what size of data platforms and which study designs do we need to assess safety issues?
    Vera E Valkhoff
    Department of Medical Informatics, Erasmus University Medical Center, Dr, Molewaterplein, Rotterdam, The Netherlands
    BMC Pediatr 13:192. 2013
    ..The purpose of this study was to investigate the utilization of NSAIDs among children in four European countries as part of the Safety Of non-Steroidal anti-inflammatory drugs (SOS) project...
  2. ncbi Prescription of nonselective NSAIDs, coxibs and gastroprotective agents in the era of rofecoxib withdrawal - a 617,400-patient study
    V E Valkhoff
    Department of Medical Informatics, Erasmus University Medical Centre, Rotterdam, The Netherlands
    Aliment Pharmacol Ther 36:790-9. 2012
    ..Gastroprotective strategies are recommended for nonsteroidal anti-inflammatory drug (NSAID) users at risk of upper gastrointestinal (UGI) complications...
  3. ncbi Adherence to gastroprotection during cyclooxygenase 2 inhibitor treatment and the risk of upper gastrointestinal tract events: a population-based study
    Vera E Valkhoff
    Erasmus University Medical Centre, Rotterdam, The Netherlands
    Arthritis Rheum 64:2792-802. 2012
    ..We undertook this study to determine the association between GPA adherence and UGI tract events among patients receiving coxibs...
  4. ncbi Risk factors for gastrointestinal bleeding associated with low-dose aspirin
    Vera E Valkhoff
    Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, The Netherlands
    Best Pract Res Clin Gastroenterol 26:125-40. 2012
    ..In patients with a history of peptic ulcer disease, Helicobacter pylori infection should be assessed and treated. This review focuses on the evidence for upper gastrointestinal risk factors in aspirin users...
  5. ncbi Time-trends in gastroprotection with nonsteroidal anti-inflammatory drugs (NSAIDs)
    V E Valkhoff
    Department of Gastroenterology and Hepatology, Erasmus University Medical Centre, Rotterdam, The Netherlands
    Aliment Pharmacol Ther 31:1218-28. 2010
    ..Preventive strategies are advocated in patients at risk of upper-gastrointestinal complications associated with nonsteroidal anti-inflammatory drugs (NSAIDs)...
  6. ncbi Risk of recurrent myocardial infarction with the concomitant use of clopidogrel and proton pump inhibitors
    V E Valkhoff
    Department of Gastroenterology and Hepatology, Erasmus University Medical Centre, Rotterdam, The Netherlands
    Aliment Pharmacol Ther 33:77-88. 2011
    ..The association between myocardial infarction (MI) and co-administration of proton pump inhibitors (PPIs) and clopidogrel remains controversial...
  7. pmc Cyclo-oxygenase-2 inhibitors or nonselective NSAIDs plus gastroprotective agents: what to prescribe in daily clinical practice?
    G M C Masclee
    Department of Medical Informatics, Erasmus University Medical Centre, Rotterdam, The Netherlands
    Aliment Pharmacol Ther 38:178-89. 2013
    ....